January 2010

Incentive Compensation

December 29, 2009

As the new environment of pharma sales shifts to more specialized and consumer-centric approaches, the industry will need to respond to ­adequately compensate and incentivize its sales teams. Our experts say prescription numbers will remain the predominant measurement for sales rep performance in the near term, but eventually, the industry will have to create IC […]

Partners in Public Health

December 28, 2009

The first influenza pandemic of the 21st century is under way. H1N1 influenza A has affected more than 207 countries and overseas territories worldwide, according the World Health Organization. As of the end of November 2009, 622,482 cases have been reported, including more than 7,820 deaths. In April 2009, the WHO declared the virus a […]

Executive Coaching

December 28, 2009

The goal of coaching is the goal of good ­management: and that is to make the most of an organization’s valuable resources — ­Harvard Business Review he International Coach Federation (ICF), one of the largest worldwide resources for professional coaches, defines coaching as partnering with clients in a thought-provoking and creative process that inspires them […]

Dr. Thomas Steitz: The Right Chemistry

December 28, 2009

Brilliance begets brilliance, and from early in his career, Thomas Steitz, Ph.D., has learned from and kept company with some of the most highly lauded scientific minds of the 20th and 21st centuries. Over the years, breakthrough discoveries regarding the ribosome have led to Dr. Steitz being often cited and honored by his peers as […]

Pharmaceutical Manufacturing Under Scrutiny

December 28, 2009

Across the board — from labeling and marketing, to clinical trials, to manufacturing processes — regulators are becoming more active in safeguarding the public and ensuring the safety of pharmaceuticals. Even before the news broke regarding Genzyme Corp.’s recent virus and contamination problems (bits of steel, rubber, and fiber were found in drugs made by […]

Name That Brand: A Pilot Program

December 28, 2009

The eventual outcome of the FDA’s two-year Proprietary Name Review pilot project may have positive implications for the industry in the long run, but in the short term, it means more money spent and more time pressure for marketers. Our experts say the burden on pharma companies to conduct their own testing and evaluation will […]

Last Word

December 28, 2009

taking stock of the media After the two-day hearing, do you believe FDA officials have a better ­understanding of social media and what the industry is trying to achieve? Gratton: I think we are at the beginning of the process. Does the FDA understand all of the nuances of the digital landscape — Web 2.0, […]

Talent Pool

December 28, 2009

Biotechnology POOL Dr. Diane JORKASKY Aileron Therapeutics Appoints Medical Chief Aileron Therapeutics, a biotechnology company discovering and developing a novel class of therapeutics called stapled peptides, has appointed Diane Jorkasky, M.D., senior VP, head of development and chief medical officer. Dr. Jorkasky directs Aileron’s emerging development, clinical research, and regulatory activities across multiple therapeutic areas. […]


December 28, 2009

E-upgrades and enhancements Prolifiq’s recent software release, Prolifiq for Life Sciences, is designed to help pharma, biotech, and medical-device companies comply with an increasingly complex web of regulations governing electronic sales communications. Constantly evolving guidelines, regulations, and laws from multiple governmental bodies make it increasingly difficult for life-sciences companies to provide scientific, promotional, and educational […]

What’s New

December 28, 2009

Oncology Performance Edge, Health Strategies Group’s recently launched strategic research service, helps marketing and sales executives in the oncology field improve brand performance by understanding how best to invest their resources. “The oncology market is significantly different from others, with unique challenges,” observes Denise Woltemath, senior consultant for specialty/bio at Health Strategies. “It faces a […]


December 28, 2009

Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Most Americans Want More Info on New Biotechnologies Sidebars: What Do You Think Synthetic Biology Is? Rating the Best Drivers of Attendance to speaker events Pharma Rebranding of Speaker Events Is Paying Off Japan Presents Opportunities, ­Challenges for Generic Manufacturers Sidebars: Blockbusters Expected to Come […]


December 28, 2009

Honors and Awards GCPj Bestows Honors The Global Clinical Practices Journal (GCPj) recognized several ­companies in 2009 for ­providing excellence in the clinical trials industry: • Chiltern’s Katie Huffine, BSN, MSN, won Project Manager of the Year. • Cognizant and AstraZeneca won the ­Clinical Research Excellence (CRE) Data Management Team of the Year Award. • […]

Letter from the Editor

December 28, 2009

Publisher Lisa Banket Editor Taren Grom Creative Director Marah Walsh Managing EDitor Denise Myshko Senior EDitor Robin Robinson features EDitor Kim Ribbink Contributing Editor Carolyn Gretton design associate Ariel Medel national account manager Cathy Tracy CIRCULATION Assistant Kathy Deiuliis Copyright 2010 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Ten, Number One PharmaVoice […]